Rate My Professor Madhavan Nair

Dr. Nair's investigations have significantly shaped the fields of HIV research and nanotechnology within Medicine, focusing on neuroAIDS progression influenced by drugs of abuse such as alcohol, cocaine, morphine, and methamphetamine. He developed innovative nanotechnology platforms, including magneto-electric nanoparticles enabling externally controlled release of anti-HIV drugs like AZTTP across the blood-brain barrier. Among his landmark contributions are the discovery of suppressor factors in cancer serum (1978), the first report of diminished natural killer cell activity in intravenous drug users (1986), morphine-induced apoptosis in lymphocytes (1997), biological activities of HIV recombinant gene products (PNAS, 1988), cocaine's upregulation of HIV co-receptors enhancing infection susceptibility, and methamphetamine's exacerbation of HIV replication in dendritic cells. With over 300 peer-reviewed publications (170 at FIU), two edited scientific books, 17 U.S. patents, and more than $25 million in research funding chiefly from NIH—including FIU's inaugural MERIT Award (2008-2018)—Dr. Nair earned accolades such as Fellow of the National Academy of Inventors (2019), University of Michigan Distinguished Research Scientist Award (1990), SUNY Exceptional Research Scholar Award (2005), and various FIU honors. He mentored over 50 students across levels and contributed to NIH study sections since 1980, organizing conferences and chairing sessions.